Purified recombinant Human RANK Receptor protein Expression System: E.coli Bioactivity: Determined by its ability to suppress the production of IFN-gamma from human PBMCs.
Spezies: Human
Wirt: Escherichia coli (E. coli)
Recombinant
< 98 % by SDS-PAGE gel and HPLC analyses.
Active
Applikationshinweise
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Reconstitute in water to a concentration of 0.1-1.0 mg/mL.
Buffer
Lyophilized from 10 mM Na3PO4, pH 7.2.
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
4 °C/-20 °C
Informationen zur Lagerung
Store at 4 °C until reconstitution. Following reconstitution aliquot and freeze at -20 °C for long term storage.
Target
RANK Receptor
Hintergrund
RANKL and RANK are members of the TNF superfamily of ligands and receptors that play an important role in the regulation of specific immunity and bone turnover. RANK (receptor) was originally identified as a dendritic-cell-membrane protein, which by interacting with RANKL augments the ability of dendritic cells to stimulate naive T cell proliferation and to promote the survival of RANK + T cells. RANK is also expressed in a variety of tissues including skeletal muscle, thymus, liver, colon, small intestine and adrenal gland. The RANK/RANKL interaction is important in the regulation of osteoclastogenesis and in dendritic-cell-mediated T cell immune responses. Impairments in RANK signaling have been implicated in the induction of expansile osteolysis and Paget disease of bone (PDB2). Alternative Names: TNFRSF11A protein, osteoclast differentiation factor receptor protein, ODFR protein, osteoclast differentiation and activation receptor protein, ODAR protein, TRANCE Receptor protein